Analyst Price Targets — SHOP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 17, 2026 11:09 am | — | Truist Financial | $150.00 | $112.70 | TheFly | Shopify upgraded to Buy at Truist amid market dislocation |
| February 16, 2026 10:28 pm | Samad Samana | Jefferies | $125.00 | $112.70 | TheFly | Shopify price target lowered to $125 from $160 at Jefferies |
| February 12, 2026 3:33 pm | Bhavin Shah | Deutsche Bank | $175.00 | $110.00 | StreetInsider | Shopify (SHOP) PT Lowered to $175 at Deutsche Bank |
| February 12, 2026 2:47 pm | — | CIBC | $185.00 | $105.87 | TheFly | Shopify price target lowered to $185 from $200 at CIBC |
| February 12, 2026 2:22 pm | — | RBC Capital | $170.00 | $106.29 | TheFly | Shopify price target lowered to $170 from $200 at RBC Capital |
| February 12, 2026 2:12 pm | — | Wedbush | $160.00 | $105.58 | TheFly | Shopify price target lowered to $160 from $185 at Wedbush |
| February 12, 2026 1:45 pm | Deepak Mathivanan | Cantor Fitzgerald | $126.00 | $109.71 | TheFly | Shopify price target lowered to $126 from $181 at Cantor Fitzgerald |
| February 12, 2026 1:26 pm | — | BMO Capital | $160.00 | $111.55 | TheFly | Shopify price target raised to $160 from $150 at BMO Capital |
| February 12, 2026 1:11 pm | — | Robert W. Baird | $160.00 | $110.70 | TheFly | Shopify price target lowered to $160 from $180 at Baird |
| February 12, 2026 1:01 pm | Trevor Young | Barclays | $130.00 | $109.91 | TheFly | Shopify price target lowered to $130 from $140 at Barclays |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for SHOP

APG Asset Management N.V. grew its position in Shopify Inc. (NASDAQ: SHOP) (TSE: SHOP) by 1.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 739,559 shares of the software maker's stock after buying an additional 12,300 shares

Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. SBRA projects 4.9%-5.4% FFO growth and plans over $450 million in investments for 2026, with a solid pipeline and a good debt schedule. Leverage is steady at 5x, with recent refinancing extending maturities and reducing interest costs, supporting financial flexibility.

Recently, Zacks.com users have been paying close attention to Shopify (SHOP). This makes it worthwhile to examine what the stock has in store.

ETSY's marketplace reset, focused capital allocation and cheaper valuation put it ahead of SHOP at current levels.

CrowdStrike Holdings is an AI-integrated leader in a complex and high-stakes cybersecurity field. Snowflake is a crucial data layer for AI, making it an ally, not an adversary.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
